AngioPlex OCT Angiography from Zeiss Medical Technology is the first such technology to receive 510(k) clearance from the U.S. Food and Drug Administration. With a single additional OCT scan that takes just seconds on the Cirrus HD-OCT system, images of the retinal vasculature at a depth and clarity not previously available can be obtained.
AngioPlex OCT Angiography delivers high-resolution, depth-resolved visualization of the separate layers of the retinal and choroidal vasculature without the need for injection of a contrast dye. In addition, FastTrac enables follow-up OCT angiography images to be acquired at the same location for monitoring of treatment efficacy and disease progression. AngioPlex OCT Angiography can complement traditional FA as a safe and efficient part of routine eye care, potentially enabling earlier detection and management of micro-progressions. For more information, see the Zeiss website.